For the first time, Parkinson’s researchers have made human brain cells derived from the skin cells of patients who carry a mutated gene related to Parkinson’s disease. This means researchers can now track exactly how this mutation, in a gene called parkin, causes the disease in about 10 percent of Parkinson’s patients.
In a move signaling the beginning of a new age in stem cell research, the Food and Drug Administration (FDA) has approved the first-ever clinical trial of stem cell therapy on human subjects. The trial, funded by the biotech company Geron, will test a procedure to repair spinal cord damage.
U.S. cloning expert Martin Pera on the Korean cloning scandal, self-correcting science and the importance of sound PR
By Greg Mone
Posted 02.16.2006 at 3:00 am 0 Comments
This January, news that South Korean scientist Hwang Woo Suk fabricated research on cloned human stem cells brought more negative attention to an already controversial field. Hwang´s work had been believed to be a breakthrough. His technique for cloning embryonic stem cells genetically matched to patients might have been used by scientists worldwide to cure disease.
Five amazing, clean technologies that will set us free, in this month's energy-focused issue. Also: how to build a better bomb detector, the robotic toys that are raising your children, a human catapult, the world's smallest arcade, and much more.